Survival of patients with multiple myeloma in first-line treatment: thalidomide, dexamethasone and zoledronic acid. Report of the National Cancer Institute of México (INCan) by Espinoza-Zamora, J.R, Labardini-Méndez, J.R, Zapata-Canto, N.P, Aguilar-Rodríguez, M, Vieyra-García, M, Sosa-Espinoza, A, González C, L, Fierro-García, M.G, Nolasco-Medina, D.B, Ríos-Contreras, J.G, Torres-Flores, J.C, Espinoza-Zamora, V.J, Velázquez-Figueroa, J.M, Lozano-Zavaleta, V, Candelaria-Hernández, G.M, Oñate-Ocaña, L.F, Cervera-Ceballos, E.E, Meneses-García, A.A

Get full text

PCN124 BUDGET IMPACT ANALYSIS OF IMMUNOTHERAPY AS SECOND-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AT MEXICO´S NATIONAL INSTITUTE OF CANCER by Barrón-Barrón, F., Meneses-García, A.A., Rivera, L.M., de la Garza-Salazar, J., Cardona, A.F., Arrieta, O.G., Chávez Millan, F., Palafox Torres, D., Paladio Hernández, J.Á.

Get full text

P2.26 Budget Impact Analysis of Immunotherapy as Second-line Treatment of NSCLC at MX's National Institute of Cancer by Tirado, L.A. Ramírez, Barrón, F., Barron, L. Zatarain, Álvarez, M.P. Peralta, Meneses-García, A.A., Ruíz-Godoy, L.M., De La Garza Salazar, J., Torres, D.I. Palafox, Millan, M.F. Chávez, Hernández, J.Á. Paladio, Cardona, A.F., Arrieta, O.

Get full text

C-Reactive protein and nutrition in oncology patients by Serna Thomé, M.G., Leal Gonzalez, G.D., Álvarez del Castillo, H., López Basave, H.N., Padilla Rosciano, A.E., Miranda Devora, G., Meneses García, A.A.

Get full text